(NYSE: RMD) Resmed's forecast annual revenue growth rate of 6.65% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.56%.
Resmed's revenue in 2023 is $4,375,020,000.On average, 6 Wall Street analysts forecast RMD's revenue for 2024 to be $688,347,776,330, with the lowest RMD revenue forecast at $675,962,343,324, and the highest RMD revenue forecast at $699,922,144,544. On average, 6 Wall Street analysts forecast RMD's revenue for 2025 to be $734,541,696,482, with the lowest RMD revenue forecast at $721,123,972,451, and the highest RMD revenue forecast at $753,919,584,705.
In 2026, RMD is forecast to generate $780,599,262,433 in revenue, with the lowest revenue forecast at $764,848,513,618 and the highest revenue forecast at $805,248,189,251.